Incyte to Report Third Quarter 2008 Financial Results and Provide Update on Drug...

* Reuters is not responsible for the content in this press release.

Thu Oct 23, 2008 7:40am EDT 

Incyte to Report Third Quarter 2008 Financial Results and Provide Update on Drug Discovery & Development Programs on November 6

WILMINGTON, Del.--(Business Wire)--
Incyte Corporation (Nasdaq:INCY) announced today that it has
scheduled its third quarter 2008 financial results conference call for
8:30 a.m. ET on Thursday, November 6, 2008. The schedules for the
press release and conference call are as follows:

   --  Q3 2008 Press Release: November 6, 2008 at 7:00 a.m. ET

   --  Q3 2008 Conference Call: November 6, 2008 at 8:30 a.m. ET

   --  Domestic Dial In Number: 877-407-8037

   --  International Dial In Number: 201-689-8037

   --  Conference ID # 300368

   If you are unable to participate, a replay of the conference call
will be available for thirty days. The replay dial-in number for the
U.S. is 877-660-6853 and dial-in number for international callers is
201-612-7415. To access the replay you will need the conference
account number 278 and the ID number 300368.

   The conference call will also be webcast live on CCBN and can be
accessed at www.incyte.com under Investor Relations, Events and
Webcasts.

   About Incyte

   Incyte Corporation is a Wilmington, Delaware-based drug discovery
and development company focused on developing proprietary small
molecule drugs to treat serious unmet medical needs. Incyte's pipeline
includes multiple compounds in Phase I and Phase II development for
oncology, inflammation and diabetes. For additional information on
Incyte, visit the Company's web site at www.incyte.com.

Incyte Corporation
Pamela M. Murphy
Vice President, Investor Relations
& Corporate Communications
302-498-6944

Copyright Business Wire 2008
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.